jrnl1125

Publication Venue For

  • Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease.  309:100-110. 2017
  • T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.  297:1-8. 2016
  • IFNγ inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms.  267:20-27. 2014
  • Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis.  273:85-95. 2014
  • IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis.  263:43-54. 2013
  • Immunological functioning in Alzheimer's disease: Differential effects of relative left versus right temporoparietal dysfunction.  263:128-132. 2013
  • The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis.  264:127-129. 2013
  • Sex hormone-dependent attenuation of EAE in a transgenic mouse with astrocytic expression of the RNA regulator HuR.  246:34-37. 2012
  • Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.  243:81-88. 2012
  • Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.  223:92-99. 2010
  • Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.  220:99-103. 2010
  • Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.  219:54-63. 2010
  • Erratum to "The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial" [J. Neuroimmunol. 201-202(2008)80-84] (DOI:10.1016/j.jneuroim.2008.05.031).  217:103. 2009
  • Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen.  217:51-54. 2009
  • Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis.  207:18-23. 2009
  • Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis.  206:22-27. 2009
  • The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial.  201-202:80-84. 2008
  • Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats.  195:47-59. 2008
  • Identification of pyruvate kinase as an antigen associated with Tourette syndrome.  181:165-176. 2006
  • Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.  179:132-144. 2006
  • PSGL-1 is not required for development of experimental autoimmune encephalomyelitis.  166:193-196. 2005
  • Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway.  164:66-75. 2005
  • CRH stimulates POMC activity and corticosterone production in dermal fibroblasts.  162:97-102. 2005
  • Neuroimaging in human immunodeficiency virus infection.  157:153-162. 2004
  • An IgM anti-MBP Ab in a case of Waldenstrom's macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE.  113:163-169. 2001
  • Highly related immunoglobulin light chain sequences in different multiple sclerosis patients.  100:98-101. 1999
  • Adhesion molecule expression and regulation on cells of the central nervous system.  98:77-88. 1999
  • Interleukin-6 expression and regulation in astrocytes.  100:124-139. 1999
  • HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues.  92:152-159. 1998
  • Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-κB and C/EBP isoforms.  92:196-207. 1998
  • Kinase inhibitors abrogate IFN-γ-induced class II transactivator and class II MHC gene expression in astroglioma cell lines.  85:174-185. 1998
  • Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes.  78:47-56. 1997
  • Induction of RANTES expression by astrocytes and astrocytoma cell lines.  71:207-214. 1996
  • Preferential association of Vλx light chains with γ2a heavy chains in naturally occurring human myelin basic protein reactive antibodies.  70:15-20. 1996
  • The kinetics of ACTH expression in rat leukocyte subpopulations.  63:103-112. 1995
  • Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity.  59:57-63. 1995
  • Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes.  51:209-220. 1994
  • Role of arcuate nucleus of the hypothalamus in the acquisition of association memory between the CS and US.  50:109-114. 1994
  • Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells.  48:221-226. 1993
  • Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine.  45:137-145. 1993
  • The identity of the unconditioned stimulus to the central nervous system is interferon-β.  45:75-81. 1993
  • The structure of a myelin basic protein-associated idiotope.  46:235-243. 1993
  • Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein.  39:231-242. 1992
  • Immune processing of proteolipid protein by subsets of antigen-presenting spleen cells.  38:139-146. 1992
  • Interferon-gamma regulation of C3 gene expression in human astroglioma cells.  38:275-282. 1992
  • Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells.  36:179-191. 1992
  • Corticotropin-releasing factor upregulates expression of two truncated pro-opiomelanocortin transcripts in murine lymphocytes.  31:51-58. 1991
  • Expression of immunoreactive growth hormone in leukocytes in vivo.  33:43-54. 1991
  • Functional assessment and partial characterization of [3H](+)-pentazocine binding sites on cells of the immune system.  35:153-166. 1991
  • Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway.  28:53-61. 1990
  • Immunomodulatory characteristics of a novel antiproliferative protein, suppressin.  30:179-187. 1990
  • Immunoreactive growth hormone-releasing hormone in rat leukocytes.  29:1-13. 1990
  • Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-γ and tumor necrosis factor-α.  30:189-200. 1990
  • Induction and regulation of interleukin-6 gene expression in rat astrocytes.  30:201-212. 1990
  • The development and characterization of encephalitogenic cloned T cells specific for myelin proteolipid protein.  26:139-145. 1990
  • Tumor necrosis factor production and receptor expression by a human malignant glioma cell line, D54-MG.  30:1-13. 1990
  • Interleukin-2 induction of ACTH secretion: presence of an interleukin-2 receptor α-chain-like molecule on pituitary cells.  21:249-254. 1989
  • Monoclonal idiotypic and anti-idiotypic antibodies produced by immunization with peptides specified by a region of human myelin basic protein mRNA and its complement.  22:157-166. 1989
  • The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein.  21:183-191. 1989
  • Tumor necrosis factor-α enhances interferon-γ-mediated class II antigen expression on astrocytes.  25:209-219. 1989
  • Response of human glioblastoma cells to recombinant interleukin-2.  17:301-314. 1988
  • An antibody to a peptide specified by an RNA that is complementary to γ-endorphin mRNA recognizes an opiate receptor.  12:329-337. 1986
  • Neuroendocrine peptide hormones and their receptors in the immune system. production, processing and action.  10:31-40. 1985